Reuters: Health
Australia says its purchase of 10 million coronavirus test kits from Chinese genomics company BGI will not risk patient privacy, as researchers hope for greater price competition in a biotech market dominated by a U.S rival.
Subscribe UsPopular Posts
|
No comments:
Post a Comment